Metandienone


Concise Prescribing Info
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Adult : PO Adjunct in senile and postmenopausal osteoporosis; Promote constructive anabolism of proteins 5-10 mg/day, increase by 2.5 mg every 2nd or 3rd day.
Dosage Details
Oral
Adjunct in senile and postmenopausal osteoporosis, Promote constructive anabolism of proteins
Adult: 5-10 mg daily, increase by 2.5 mg every 2nd or 3rd day.
Contraindications
In men, prostate or breast carcinoma. Severe hepatic impairment. Hypercalcaemia, hypercalciuria. Pregnancy.
Special Precautions
Lactation; CV disorders, renal/hepatic impairment, epilepsy, migraine, DM, conditions aggravated by fluid retention. Children. Monitor hepatic function.
Adverse Reactions
Fluid and electrolyte retention; psychiatric effects; hypercalcaemia, impaired glucose tolerance. Men: Impotence, gynaecomastia, hirsutism, male-pattern baldness, acne, seborrhoea, oedema, cholestatic jaundice. Women: Amenorrhoea, menstrual irregularities. Children: Premature closure of epiphyses, stops linear growth; virilisation symptoms.
Potentially Fatal: Hepatotoxicity.
Drug Interactions
May enhance effects of antidiabetics, ciclosporin, levothyroxine, warfarin. Resistance to the effects of neuromuscular blockers may occur.
Lab Interference
May interfere with glucose tolerance and thyroid function tests.
Action
Description: Metandienone possesses anabolic, some androgenic and little progestogenic activity.
MIMS Class
Disclaimer: This information is independently developed by MIMS based on Metandienone from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in